Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative
Journal of Surgical Oncology · 2024-06 · 129 (7) · 1354-1363
DOI: 10.1002/jso.27620 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, 2024-04. Verfasst von Eleftherios A Makris und 17 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Undifferentiated pleomorphic sarcoma (UPS) is a relatively rare but aggressive neoplasm. We sought to utilize a multi‐institutional US cohort of sarcoma patients to examine predictors of survival and recurrence patterns after resection of UPS.
Methods
From 2000 to 2016, patients with primary UPS undergoing curative‐intent surgical resection at seven academic institutions were retrospectively reviewed. Epidemiologic and clinicopathologic factors were reviewed by site of origin. Overall survival (OS), recurrence‐free survival (RFS), time‐to‐locoregional (TTLR), time‐to‐distant recurrence (TTDR), and patterns of recurrence were analyzed.
Results
Of the 534 UPS patients identified, 53% were female, with a median age of 60 and median tumor size of 8.5 cm. The median OS, RFS, TTLR, and TTDR for the entire cohort were 109, 49, 86, and 46 months, respectively. There were no differences in these survival outcomes between extremity and truncal UPS. Compared with truncal, extremity UPS were more commonly amenable to R0 resection (87% vs. 75%, p = 0.017) and less commonly associated with lymph node metastasis (1% vs. 6%, p = 0.031). R0 resection and radiation treatment, but not site of origin (extremity vs. trunk) were independent predictors of OS and RFS. TTLR recurrence was shorter for UPS resected with a positive margin and for tumors not treated with radiation.
Conclusion
For patients with resected extremity and truncal UPS, tumor size >5 cm and positive resection margin are associated with worse survival OS and RFS, irrespectively the site of origin. R0 surgical resection and radiation treatment may help improve these survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgical Oncology, Stanford University, Stanford, California, USA.
- Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
- Surgical Oncology, The Ohio State University, Columbus, Ohio, USA.
- Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Surgical Oncology, University of Chicago Medicine, Chicago, Illinois, USA.
- Surgical Oncology, Wake Forest University, Winston-Salem, North Carolina, USA.
Zitieren
APA
Makris, E. A., Tran, T. B., Delitto, D. J., Lee, B., Ethun, C. G., Grignol, V., Harrison Howard, J., Bedi, M., Clark Gamblin, T., Tseng, J., Roggin, K. K., Chouliaras, K., Votanopoulos, K., Cullinan, D., Fields, R. C., Cardona, K., Poultsides, G., & Kirane, A. (2024). Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative. Journal of Surgical Oncology, 129(7), 1354-1363. https://doi.org/10.1002/jso.27620
Vancouver
Makris EA, Tran TB, Delitto DJ, Lee B, Ethun CG, Grignol V, et al. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative. Journal of Surgical Oncology. 2024;129(7):1354-1363. doi:10.1002/jso.27620
BibTeX
@article{Makris2024,
author = {Makris, Eleftherios A and Tran, Thuy B and Delitto, Daniel J and Lee, Byrne and Ethun, Cecilia G and Grignol, Valerie and Harrison Howard, J and Bedi, Meena and Clark Gamblin, T and Tseng, Jennifer and Roggin, Kevin K and Chouliaras, Konstantinos and Votanopoulos, Konstantinos and Cullinan, Darren and Fields, Ryan C and Cardona, Kenneth and Poultsides, George and Kirane, Amanda},
title = {Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative},
journal = {Journal of Surgical Oncology},
year = {2024},
volume = {129},
number = {7},
pages = {1354--1363},
doi = {10.1002/jso.27620}
}
EUVIMED